Quantcast

Latest Oncology Stories

2014-07-24 08:34:35

WASHINGTON, July 24, 2014 /PRNewswire/ -- The Mesothelioma Compensation Center knows that many diagnosed victims of mesothelioma, or their family members discount the compensation possibilities because of the age of the victim, and as they would like to explain with one call to 866-714-6466 this can be a gigantic mistake for the victim, or their family members. According to the CDC the average of a diagnosed victim of mesothelioma is 72 years old. http://MesotheliomaCompensationCenter.Com...

2014-07-23 23:29:47

The Mesothelioma Compensation Center is urging the family members of a diagnosed victim of this rare form of cancer to call them at 866-714-6466 for information on the best possible compensation. This week the group is offering to create a comprehensive “must do” checklist that covers all of the bases for the victim and their family members that includes treatment options. http://MesotheliiomaCompensationCenter.Com (PRWEB) July 22, 2014 The Mesothelioma Compensation Center is urging...

2014-07-23 23:23:34

LIVESTRONG houses PAF representative in its Cancer Navigation Center. Austin, Texas (PRWEB) July 22, 2014 For the past nine years, the LIVESTRONG Foundation and Patient Advocate Foundation (PAF) have been working in tandem to help thousands of cancer patients and survivors understand their insurance options, facilitate access to care, and help survivors connect to resources dealing with work discrimination issues. In 2014, the two foundations expanded their partnership to include...

2014-07-23 23:18:30

Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html Albany, New York (PRWEB) July 22, 2014 According to a new market report published by Transparency Market Research “Circulating Circulating Tumor Cells (CTCs)...

2014-07-23 23:05:38

The Circuelle Foundation wants women to know leading researchers believe breast self-exams make a significant impact in detecting breast cancer. SARASOTA, Fla. (PRWEB) July 23, 2014 The Circuelle Foundation compiled and released independent research results from leading academic institutions uncovering the importance of breast self-exams (BSE). The historical events and opinions surrounding the need for breast self-exams is contradictory and can be confusing at best, but there is proof...

2014-07-23 23:01:05

The Firm is evaluating potential legal claims on behalf of women who allegedly experienced the spread of uterine sarcoma and other cancers due to uterine morcellation New York, New York (PRWEB) July 23, 2014 A new study has uncovered additional evidence that the use of a power morcellator (http://www.injurybeacon.com/power-morcellator/) during minimally invasive hysterectomies can spread undetected uterine sarcoma and other cancers throughout a woman’s body, Bernstein Liebhard LLP...

2014-07-23 16:28:25

WHITE PLAINS, N.Y., July 23, 2014 /PRNewswire-USNewswire/ -- Today's U.S. Food and Drug Administration (FDA) approval of idelalisib to treat patients with relapsed chronic lymphocytic leukemia (CLL), follicular lymphoma (FL) and small lymphocytic lymphoma (SLL) is a significant advance for patients with these blood cancers. Idelalisib, which goes by the trade name Zydelig®, is a first-in-class inhibitor of PI3K delta, a protein that is highly expressed in many B-cell malignancies...

2014-07-23 12:32:39

HOUSTON, July 23, 2014 /PRNewswire-USNewswire/ -- V. Craig Jordan, Ph.D., one of the world's preeminent breast cancer experts will join The University of Texas MD Anderson Cancer Center this fall. Jordan is considered the "Father of Tamoxifen," the groundbreaking therapeutic drug that has saved countless lives. http://photos.prnewswire.com/prnvar/20140723/129913 As a professor in Breast Medical Oncology and Molecular and Cellular Oncology, Jordan will focus on the new biology of...

2014-07-23 12:31:07

PISCATAWAY, N.J., July 23, 2014 /PRNewswire/ -- Clearview Diagnostics, Inc. as part of a compendium, announced today the receipt of a grant from the NIH (National Institute of Health) to develop a portable self-reading device for breast cancer screening. Clearview will be working with the Dr. Susan Love Research Foundation to develop portable, self-reading ultrasound for breast screening. The focus of these development efforts and the directive with this grant is toward a low-cost...

2014-07-23 08:37:25

Oncology-specific information technology (IT) solutions among the service offerings Varian is showcasing at the 2014 annual AAPM meeting in Austin this week AUSTIN, Texas, July 23, 2014 /PRNewswire/ -- e+CancerCare, a leading operator of outpatient cancer care centers in the U.S. including Rocky Mountain Oncology Center in Wyoming, OncoLogics in Louisiana, Laurel Cancer Care in Mississippi, Community Cancer Center of North Florida and South Georgia Center for Cancer Care, recently...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.